[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioCentury "Rare disease setbacks for Ultragenyx mid-stage win for Rhythm. Plus: Astrazeneca and Takeda preparing submissions after Phase III readouts in this weeks Clinical Report"
@BioCentury on X 2025-07-15 22:30:12 UTC 16.3K followers, XXX engagements

"Third patient dies from acute liver failure caused by a Sarepta gene therapy"
@BioCentury on X 2025-07-18 00:00:08 UTC 16.3K followers, 92.9K engagements

"BioCentury's latest biopharma Management Moves: Steve Bates longtime head of BIA named executive chair of U.K.s Office of Life Sciences. Plus: Novartis names Mazuk chief patient experience officer and updates from Seres and ABPI"
@BioCentury on X 2025-07-22 22:30:04 UTC 16.3K followers, XXX engagements

"Lundbeckfondens Jacob Falck Hansen becomes CEO of portfolio company Vesper Bio. Also in BioCentury's Management Moves Column:Oncolytics reunitesAromando with new CEO Kelly and updates fromGalderma JadeOutlookAvacta andZura"
@BioCentury on X 2025-07-02 01:30:08 UTC 16.3K followers, XXX engagements

"BioCentury's latest management tracks: Stumpe an alum of Tempus and Google named chief tech officer at Danaher. Plus: Updates from Cardiff Regenics X-chem"
@BioCentury on X 2025-06-28 00:30:09 UTC 16.3K followers, XXX engagements